Clinical Trials Directory

Trials / Completed

CompletedNCT05362604

Prenatal Diagnosis of the Fetal Esophageal or Intestinal Atresia

Top Benefits of the Prenatal Diagnosis of the Fetal Esophageal or Intestinal Atresia

Status
Completed
Phase
Study type
Observational
Enrollment
51 (actual)
Sponsor
Poitiers University Hospital · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Aim- to investigate how prenatal diagnosis of fetal esophageal or intestinal atresia impacts obstetric and neonatal outcomes. Methods- This was a retrospective cohort study at a single center. The study population comprised 51 consecutive pregnancies, including 29 mothers (57%) and their fetuses affected by prenatally diagnosed fetal esophageal or intestinal atresia, and 22 mothers (43%) and their babies with postnatally diagnosed fetal esophageal or intestinal atresia.

Detailed description

Aim- to investigate how prenatal diagnosis of fetal esophageal or intestinal atresia impacts obstetric and neonatal outcomes. Methods- This was a retrospective cohort study at a single center. The study population comprised 51 consecutive participants, including 29 mothers (57%) and their fetuses affected by prenatally diagnosed fetal esophageal or intestinal atresia, and 22 mothers (43%) and their babies with postnatally diagnosed fetal esophageal or intestinal atresia.

Conditions

Interventions

TypeNameDescription
PROCEDUREscheduled delivery at a tertiary centerNeonatal units in French hospitals are classified in three levels. The intention is for infants requiring high level care to receive it in a tertiary neonatal unit within the same network when appropriate. In case of known fetal gastro-intestinal artesia, the prenatal care includes obstetric consultation and level 3 ultrasound scheduled every four weeks at our unit until the end of the pregnancy, antenatal consultations with a specialized multidisciplinary team, and an antenatal visit of the birth center to reduce the parental anxiety.

Timeline

Start date
2021-04-01
Primary completion
2022-02-07
Completion
2022-02-07
First posted
2022-05-05
Last updated
2022-05-05

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05362604. Inclusion in this directory is not an endorsement.